[12] When Compounded HRT May Be Clinically Appropriate Compounded HRT fills a genuine gap when: A patient requires a dose not commercially available (e.g., low-dose estradiol 0.025 mg/mL vaginal cream) A patient has a documented allergy to a component in the commercial product (e.g., peanut oil in Prometrium) A prescriber needs a specific delivery route or combination not offered commercially The ACOG Committee Opinion No

Materials & methods Samples and immunohistochemistry We searched for information on NET, neuroendocrine carcinoma (NEC), carcinoid, middle ear adenoma/NET, olfactory neuroblastoma, paraganglioma/pheochromocytoma, cauda equina NET (CE-NET), medullary thyroid carcinoma, parathyroid adenoma, Merkel cell carcinoma, and pituitary adenoma/neuroendocrine tumors from pathology files at Tohoku University Hospital (Miyagi, Japan), Osaki Citizen Hospital (Miyagi, Japan), Aichi Prefectural Cancer Center Hospital (Nagoya, Japan), Noe Hospital (Osaka, Japan), Kansai Electric Power Hospital, and Kohnan Hospital (Miyagi, Japan)
10.1124/dmd.106.012112 70 MaroneP
Conclusion Skin reactions associated with GLP-1 medications extend beyond simple injection-site irritation